Local anesthesia can, in rare cases, be fatal. A review of more than 20 studies spanning decades of dental procedures alone found roughly 3 deaths per million patients, and that rate has been dropping over time. The condition behind most of these deaths, called local anesthetic systemic toxicity, occurs when the drug reaches the bloodstream in high enough concentrations to shut down the brain or the heart. The risk is genuinely low for the vast majority of people getting a filling, a skin biopsy, or a minor office procedure, but “low” is not “zero,” and the circumstances that push it from low toward dangerous are worth understanding.
How Local Anesthetics Work and How They Become Dangerous
Local anesthetics block the sodium channels that nerve cells use to fire electrical signals. When injected near a target nerve, the drug keeps pain signals from reaching your brain. That blockade is temporary and, when confined to the injection site, harmless. The trouble starts when the drug enters your bloodstream in large enough quantities to block sodium channels elsewhere in the body, particularly in the brain and the heart.
The brain is usually the first organ to react. Because certain inhibitory circuits are more sensitive to sodium-channel blockade than excitatory ones, a rising blood level of local anesthetic can produce a paradoxical burst of uncontrolled nerve activity. In animal studies, intravenous infusion of local anesthetics produces seizure patterns on brain monitoring within minutes, accompanied by visible convulsions.
If blood levels continue to climb, the heart follows. Local anesthetics slow electrical conduction through heart muscle, which can cause dangerous rhythm disturbances, a drop in blood pressure, and, at high enough concentrations, cardiac arrest. In animal experiments comparing lidocaine and bupivacaine, both drugs caused severe slowing of the heart rate and low blood pressure. But there was a critical difference: when lidocaine triggered abnormal rhythms, those rhythms spontaneously corrected. When bupivacaine did the same, half the animals died.1PubMed. Cardiovascular toxicity of local anesthetics: an alternative hypothesis That distinction between shorter-acting and longer-acting agents has shaped how clinicians think about risk ever since.
The Numbers Behind Fatal Reactions
A large-scale analysis of the U.S. Food and Drug Administration’s adverse event reporting system from 1968 through 2023 identified 22,050 total adverse events linked to local anesthetics, of which 1,473 were deaths.2PubMed Central. Contemporary local anaesthetic-associated adverse events and mortality: a pharmacovigilance analysis of a US reporting system That sounds alarming until you consider how many millions of local anesthetic injections happen every year. Death reports from both major classes of local anesthetics were proportionally lower than death reports from other drugs in the same database.
In the dental setting, where local anesthesia is used more often than anywhere else, the picture is even more reassuring. A review of studies going back to 1955 found 218 deaths among more than 71 million patients, a rate of about 1 in 328,000. The death rate per million patients roughly halved between 1955 and the most recent data in 2012.3PubMed Central. Death Rate of Dental Anaesthesia Those numbers include all causes of death during dental procedures under local anesthesia, not just toxicity from the drug itself. A Japanese literature review of 38 fatal cases found that the most common causes of death fell into three categories: heart failure, cerebrovascular events like strokes, and anaphylaxis.4Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. Possible cases of dental treatment-associated death under local anesthesia in Japan: A review of the literature In other words, a patient’s pre-existing health played a major role in many of these deaths.
The Lidocaine Puzzle
If you asked most anesthesiologists a decade ago which local anesthetic was most likely to kill a patient, the answer would have been bupivacaine. It is more potent, binds more tightly to cardiac sodium channels, and has a well-earned reputation for causing difficult-to-reverse cardiac arrest. Practice advisories published over the years focused heavily on the dangers of these long-acting agents, and the effort worked. After those advisories were published, death reports linked to long-acting local anesthetics dropped by about 40%.2PubMed Central. Contemporary local anaesthetic-associated adverse events and mortality: a pharmacovigilance analysis of a US reporting system
But lidocaine deaths did not follow the same trend. Reports of death from lidocaine stayed flat over the same period, and lidocaine has emerged as the most frequently reported local anesthetic associated with death in the FDA’s adverse event database.5PubMed Central. The state of local anaesthetic systemic toxicity in 2025: the emergence of lidocaine as our next challenge The reasons are not entirely clear. One important factor is volume: lidocaine is by far the most widely used local anesthetic in the world, so even a tiny per-dose risk produces a noticeable body count. The analysis also pointed to high-dose lidocaine infusions, nerve catheter procedures, and high spinal blocks as the main contributors to lidocaine deaths since 2010.2PubMed Central. Contemporary local anaesthetic-associated adverse events and mortality: a pharmacovigilance analysis of a US reporting system
There may be a recognition problem, too. A clinical review noted that roughly three-quarters of recent fatalities attributed to local anesthetic toxicity involved lidocaine, often in outpatient settings. Early warning signs of toxicity, like agitation and trembling, were sometimes mistaken for a normal reaction to the epinephrine often mixed in with the anesthetic.6Turkish Journal of Vascular Surgery. Hidden risk of antibiotic usage and tumescent local anesthesia: A clinical review If the clinician chalks up those symptoms to a jittery patient or an adrenaline response, the window to intervene before cardiac collapse narrows.
Who Is Most at Risk
Not everyone faces the same odds. Several factors make a person more vulnerable to systemic toxicity from local anesthetics.
Age sits near the top of the list. Older adults are at disproportionately increased risk because they tend to have less muscle mass, which affects how the drug distributes through the body, and they are more likely to have conditions that slow the drug’s metabolism. A review of case reports in patients over 65 found that inadvertent overdosing accounted for some of the toxicity events, suggesting that standard dosing in younger adults may be too much for an older body.7PubMed. Local Anesthetic Toxicity in the Geriatric Population
Heart disease is another significant risk factor. Pre-existing conditions like coronary artery disease, rhythm disturbances, conduction abnormalities, and weakened pumping function all make the heart more susceptible to local anesthetic toxicity. Liver or kidney disease can also increase risk by slowing the body’s ability to break down or clear the drug, sometimes causing a delayed form of toxicity that shows up well after the injection.8APSF Newsletter. Local Anesthetic Systemic Toxicity (LAST) Revisited: A Paradigm in Evolution Frailty in general and conditions that impair the energy-producing machinery of cells (mitochondrial dysfunction) have also been identified as risk enhancers.
The practical takeaway is simple: if you have serious heart, liver, or kidney problems, or if you are elderly, make sure every clinician injecting local anesthetic knows your full medical history. The Japanese review of fatal dental cases found that two-thirds of the patients who died had either no documented relevant medical history or an inadequate description of it.4Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. Possible cases of dental treatment-associated death under local anesthesia in Japan: A review of the literature Missing information may have cost lives.
Anxiety, Fainting, and the Gray Zone Between Fear and Toxicity
Many people who feel terrible after a local anesthetic injection are not experiencing toxicity at all. Anxiety about needles or dental work can trigger a response from the vagus nerve that drops heart rate and blood pressure, sometimes causing fainting. Research on patients undergoing dental surgery has found that anxiety during a dental visit can cause a parasympathetic response leading to slowed heart rate, fainting, or even brief rhythm disturbances.9PubMed Central. Evaluation of Anxiety, Pain, and Hemodynamic Changes during Surgical Removal of Lower Third Molar under Local Anesthesia Blood pressure also tends to rise during dental surgery even in people with normal baseline pressures, driven by stress, pain, and the epinephrine in the anesthetic.
This creates a diagnostic headache for clinicians. A patient who becomes pale, sweaty, and lightheaded after an injection could be having a vasovagal faint, an anxiety-driven blood pressure spike, a reaction to epinephrine, early systemic toxicity, or a genuine allergic response. The Japanese review of fatal cases reported that 95% of adverse events began within 30 minutes of the anesthetic being given, so the timing alone does not distinguish between these possibilities.4Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. Possible cases of dental treatment-associated death under local anesthesia in Japan: A review of the literature For you as a patient, the important thing is to speak up immediately if you feel anything unusual: ringing in the ears, a metallic taste, sudden dizziness, numbness around the mouth, or muscle twitching. These are classic early signs of systemic toxicity and are distinct from the lightheaded feeling of a vasovagal episode.
True Allergy Versus Toxicity
Many patients who believe they are “allergic to local anesthetics” are actually describing a toxicity reaction or a response to epinephrine. True allergy to local anesthetics exists, but it is rare, and it behaves quite differently from toxicity. An allergic reaction involves the immune system and produces symptoms like hives, swelling, and, in the worst case, anaphylaxis with throat swelling and circulatory collapse. Toxicity, by contrast, follows a dose-dependent pattern: the higher the blood level, the worse the symptoms, progressing from tingling and dizziness to seizures and cardiac arrest.
There are two broad families of local anesthetics, esters and amides, and cross-reactivity between them is uncommon. When a patient reports a prior reaction, an allergist can usually identify an alternative agent that is safe to use. The distinction matters because labeling yourself “allergic to all local anesthetics” can lead clinicians to use general anesthesia for procedures that could have been done safely with a different local agent, and general anesthesia carries its own set of risks.
High-Volume Procedures and Dose Limits
The procedures that push local anesthetic doses highest tend to carry the greatest risk. Tumescent anesthesia, widely used in liposuction and varicose vein surgery, involves injecting very large volumes of dilute lidocaine into fatty tissue. Because fat absorbs the drug slowly, blood levels stay lower than you might expect given the total dose. A study of 41 tumescent procedures in volunteers found that doses as high as 52 mg/kg produced peak blood levels that stayed below the threshold for even mild toxicity over a 24-hour monitoring window. The researchers estimated that the risk of toxicity was no more than 1 in 2,000 at a dose of 28 mg/kg without liposuction and 45 mg/kg with liposuction.10PubMed Central. Estimated Maximal Safe Dosages of Tumescent Lidocaine
For context, traditional guidelines cap lidocaine at about 4.5 to 7 mg/kg depending on whether epinephrine is included. The tumescent technique can safely push well beyond that limit because the dilute solution and fatty tissue slow absorption dramatically. But “safely” assumes the technique is done correctly. Errors in calculation, excessively rapid injection, or injection into a more vascular area than intended can all undermine those safety margins. The same principles apply in a smaller way to any procedure using local anesthetic: dose matters, site of injection matters, and speed of injection matters.
What Saves You If Things Go Wrong
The single biggest advance in treating local anesthetic toxicity over the past two decades has been the use of intravenous lipid emulsion. This is essentially a fat solution, similar to the intravenous nutrition given to hospitalized patients, that acts as a “lipid sink.” It pulls the fat-soluble anesthetic molecules out of heart and brain tissue and into the bloodstream, where they can be metabolized and cleared. Animal data was convincing enough that the treatment spread rapidly into clinical practice, backed by successful case reports in humans.11Macedonian Medical Review. Lipid Emulsion Infusion in Resuscitation for Local Anesthetic and Other Drug Overdose Today, any facility performing regional anesthesia is expected to have lipid emulsion available.
Prevention, though, remains more important than rescue. Ultrasound guidance during nerve blocks allows clinicians to see the needle tip relative to blood vessels and nerves in real time. A study comparing ultrasound-guided injections to conventional techniques found that inadvertent placement of the needle inside a blood vessel dropped from about 14.5% with the conventional approach to under 2% with ultrasound. The ultrasound group also had zero instances of positive blood aspiration, compared to about 13% in the conventional group.12European Journal of Cardiovascular Medicine. Ultrasound-Assisted Prevention of Intravascular Injection during Dermatologic Anaesthesia In about a fifth of cases, the ultrasound scan prompted the clinician to change the planned needle path to avoid a visible blood vessel, a correction that would have been invisible without imaging.
Aspiration before injection (pulling back on the syringe to check for blood) is a traditional safety step, but it is not foolproof. Needles can shift between the aspiration and the injection, and false negatives are common. Incremental injection, giving small amounts at a time and watching for early signs of toxicity between doses, remains a standard precaution across all settings.
Over-the-Counter Products and Unexpected Risk
Not all local anesthetic exposure happens in a clinic. Benzocaine gels and sprays, sold without a prescription for teething pain, sore throats, and mouth sores, carry a specific risk that is distinct from classic systemic toxicity. Benzocaine can trigger methemoglobinemia, a condition where it chemically alters hemoglobin so it can no longer carry oxygen effectively. The result is that your blood oxygen drops even though your lungs are working fine, and in severe cases the condition is life-threatening. A case report described an elderly woman with multiple health problems who developed significant methemoglobinemia after prolonged use of an over-the-counter benzocaine gel for mouth discomfort.13PubMed Central. Over-the-Counter Benzocaine Gel as a Cause of Methemoglobinemia: A Case Report Although this complication is uncommon, it is often underrecognized, especially when it comes from a product people think of as harmless because it is sold on a pharmacy shelf.
The risk is higher in infants, in older adults, and in people with underlying blood disorders or heart and lung disease. The U.S. FDA has warned against using benzocaine products in children under two. If you are using benzocaine gel regularly or in large amounts, particularly if you have chronic health conditions, the risk of methemoglobinemia is real enough to warrant a conversation with your doctor.
Training Gaps and Why They Matter
An underappreciated piece of the safety picture is whether the person injecting you knows what to do if something goes wrong. Local anesthetic toxicity is rare enough that many clinicians go an entire career without seeing a case, which means the emergency protocol can feel unfamiliar when it is suddenly needed. A simulation-based training study measured how well multidisciplinary teams managed a simulated toxicity crisis before and after structured education. Checklist performance scores roughly doubled after the training intervention, jumping from an average of 39 out of 100 to about 84.14PubMed Central. Evaluation of a multidisciplinary simulation training curriculum for local anesthetic systemic toxicity management: a quasi-experimental study using the Kirkpatrick model in India
The gap before training is striking. A starting score of 39 means teams were missing more than half the recommended steps in a life-threatening emergency. This does not mean your dentist or dermatologist is unprepared, but it does reinforce the value of having procedures done in settings where emergency equipment and trained staff are on hand. The Japanese review found that emergency first aid was performed by the treating dentist in only half the fatal cases.4Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. Possible cases of dental treatment-associated death under local anesthesia in Japan: A review of the literature Readiness matters as much as prevention.
A Brief History of Getting Safer
The story of local anesthesia is, in many ways, a story of steadily reducing lethality. The first local anesthetic used in surgery was cocaine, introduced in the 1880s, and its toxic effects were identified almost immediately, producing deaths among patients and addiction among medical staff.15PubMed. From cocaine to ropivacaine: the history of local anesthetic drugs The crisis was severe enough that the entire field of local anesthesia might have stalled without the synthesis of safer alternatives. Between the 1890s and the 1970s, wave after wave of new agents arrived, each designed to preserve the nerve-blocking effect while reducing toxicity to the brain and heart.16PubMed. Local anesthetic systemic toxicity: a historical perspective
Modern agents are enormously safer than cocaine, but none are perfectly safe. The development of ropivacaine, for example, was motivated specifically by the cardiac dangers of bupivacaine. And the shift from blind injection techniques to ultrasound-guided ones has added another layer of protection. Each generation of improvements has pushed the fatality rate lower, but the fundamental pharmacology has not changed: these drugs block sodium channels, and if enough drug reaches the wrong sodium channels, the consequences are serious. The trend is encouraging, though. In dental anesthesia, the death rate per million has roughly halved over the past several decades.3PubMed Central. Death Rate of Dental Anaesthesia Better drugs, better techniques, better monitoring, and the availability of lipid emulsion rescue have all contributed. The risk has not been eliminated, but it has been made small enough that billions of local anesthetic injections happen safely every year.